CD33 and acute myeloid leukemia: When co-cultured with healthy donor peripheral blood mononuclear and CD33+ AML cells, CC-96191 activated NK cells but not T cells, with resulting soluble cytokine levels 10- to >100-fold lower than those resulting from treatment with a CD33/CD3 BsAb.